0001209191-19-060087.txt : 20191211 0001209191-19-060087.hdr.sgml : 20191211 20191211174945 ACCESSION NUMBER: 0001209191-19-060087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191211 FILED AS OF DATE: 20191211 DATE AS OF CHANGE: 20191211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harsh Michael CENTRAL INDEX KEY: 0001706155 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37969 FILM NUMBER: 191280535 MAIL ADDRESS: STREET 1: 3600 GREEN COURT, SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDRA Life Sciences Inc. CENTRAL INDEX KEY: 0001681682 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 260579295 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3600 GREEN COURT STREET 2: SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 BUSINESS PHONE: 734-335-0468 MAIL ADDRESS: STREET 1: 3600 GREEN COURT STREET 2: SUITE 350 CITY: ANN ARBOR STATE: MI ZIP: 48105 FORMER COMPANY: FORMER CONFORMED NAME: Endra Inc. DATE OF NAME CHANGE: 20160805 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-11 0 0001681682 ENDRA Life Sciences Inc. NDRA 0001706155 Harsh Michael 3600 GREEN COURT, SUITE 350 ANN ARBOR MI 48105 1 0 0 0 Stock option (right to buy) 0.90 2019-12-11 4 A 0 89922 0.00 A 2029-12-11 Common Stock 89922 89922 D Series A Convertible Preferred Stock 0.87 2019-12-11 4 A 0 9.618 1143.68 A 2019-12-11 Common Stock 11056 9.618 D Warrants 0.87 2019-12-11 4 A 0 11056 A 2019-12-11 2024-12-11 Common Stock 11056 11056 D These options vest and become exercisable in three equal annual installments beginning on the one year anniversary of the grant date. The Series A preferred stock has a face value of $1,000 per share and accrues dividends thereon at an annual rate of 6.0%. The face value plus accrued and unpaid dividends of the Series A preferred stock is convertible into common stock at a price per share of $0.87. The Series A preferred stock has no expiration date. The Warrants were issued for no additional consideration in connection with the purchase of the Series A preferred stock. /s/ Michael Harsh by Mark Busch, attorney-in-fact 2019-12-11